- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2009
- Public Summary Document (PSD) March 2009 PBAC Meeting - PDF
Eculizumab – March 2009
Eculizumab, solution concentrate for I.V. infusion, 300 mg in 30 mL, Soliris®, March 2009
Last updated
3 July 2009